ES2663386T3 - Novirabdovirus recombinante utilizable como vector de antígenos - Google Patents

Novirabdovirus recombinante utilizable como vector de antígenos Download PDF

Info

Publication number
ES2663386T3
ES2663386T3 ES13799108.9T ES13799108T ES2663386T3 ES 2663386 T3 ES2663386 T3 ES 2663386T3 ES 13799108 T ES13799108 T ES 13799108T ES 2663386 T3 ES2663386 T3 ES 2663386T3
Authority
ES
Spain
Prior art keywords
protein
domain
novirabdovirus
recombinant
rabdovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13799108.9T
Other languages
English (en)
Inventor
Michel Bremont
Angella NZONZA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Recherche Agronomique INRA
Original Assignee
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Recherche Agronomique INRA filed Critical Institut National de la Recherche Agronomique INRA
Application granted granted Critical
Publication of ES2663386T3 publication Critical patent/ES2663386T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20041—Use of virus, viral particle or viral elements as a vector
    • C12N2760/20043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Novirabdovirus recombinante cuyo genoma contiene, además de los genes que codifican las proteínas N, P, M, G y L endógenas de dicho novirabdovirus, un gen exógeno que codifica una proteína quimérica, caracterizándose dicha proteína quimérica porque comprende la secuencia de una proteína antigénica de interés, no siendo dicha proteína antigénica de interés una glicoproteína, fusionada en su extremo N terminal con el péptido señal de la proteína G de un rabdovirus y en su extremo C-terminal con un fragmento de secuencia de una proteína G de rabdovirus, comprendiendo dicho fragmento el dominio transmembrana de dicha proteína G de rabdovirus o una parte de ésta que comprende al menos 15 aminoácidos C-terminales consecutivos de dicho dominio, caracterizado porque comprende además, a continuación del dominio transmembrana o de la parte de éste, el dominio intravirión de una proteína G de rabdovirus, o una parte de dicho dominio intravirión, que comprende al menos 3 aminoácidos N-terminales consecutivos de dicho dominio.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6

Claims (1)

  1. imagen1
ES13799108.9T 2012-10-15 2013-10-08 Novirabdovirus recombinante utilizable como vector de antígenos Active ES2663386T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1259815 2012-10-15
FR1259815A FR2996856B1 (fr) 2012-10-15 2012-10-15 Novirhabdovirus recombinant utilisable comme vecteur d'antigenes
PCT/IB2013/059207 WO2014060905A1 (fr) 2012-10-15 2013-10-08 Novirhabdovirus recombinant utilisable comme vecteur d'antigènes

Publications (1)

Publication Number Publication Date
ES2663386T3 true ES2663386T3 (es) 2018-04-12

Family

ID=48224842

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13799108.9T Active ES2663386T3 (es) 2012-10-15 2013-10-08 Novirabdovirus recombinante utilizable como vector de antígenos

Country Status (5)

Country Link
US (1) US9907843B2 (es)
EP (1) EP2906704B1 (es)
ES (1) ES2663386T3 (es)
FR (1) FR2996856B1 (es)
WO (1) WO2014060905A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109136200B (zh) * 2018-09-20 2022-02-18 中国水产科学研究院黑龙江水产研究所 一种重组传染性造血器官坏死病毒及其构建方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136905A0 (en) * 1997-12-22 2001-06-14 Univ Tennessee Res Corp Recombinant rhabdovirus containing a heterologous fusion protein
FR2839453B1 (fr) * 2002-05-07 2007-05-11 Agronomique Inst Nat Rech Utilisation de novirhabdovirus modifies pour l'obtention de vaccins
AU2003277863B2 (en) * 2002-09-17 2007-02-22 Elanco Tiergesundheit Ag Ihnv g protein for immune stimulation
EP1867725A1 (en) * 2006-06-16 2007-12-19 Institut National De La Recherche Agronomique (Inra) Recombinant novirhabdoviruses and uses thereof
CN102083462B (zh) * 2007-08-03 2015-02-18 巴斯德研究院 慢病毒基因转移载体及其医学应用

Also Published As

Publication number Publication date
EP2906704B1 (fr) 2017-12-27
US20150265699A1 (en) 2015-09-24
WO2014060905A1 (fr) 2014-04-24
EP2906704A1 (fr) 2015-08-19
FR2996856B1 (fr) 2015-06-05
FR2996856A1 (fr) 2014-04-18
US9907843B2 (en) 2018-03-06

Similar Documents

Publication Publication Date Title
AR122964A2 (es) Péptidos útiles en la inmunoterapia contra el carcinoma hepatocelular (chc) y otros tipos de cáncer
CL2019001000A1 (es) Proteínas de fusión fc heterodiméricas il15/il15ralfa
CL2018000340A1 (es) Construcciones con un dominio sirp-alfa o sus variantes.
ES2600879T3 (es) Preparaciones que contienen el factor de Von Willebrand (FvW) y procedimientos, kits y utilizaciones relacionados con las mismas
AR108442A1 (es) Proteínas de fusión gdf15 y usos de estas
AR114339A1 (es) Plataforma de presentación, productos y métodos con endosporas basadas en paenibacillus
ES2676499T3 (es) Proteínas de fusión Fc que comprenden nuevos enlazadores o disposiciones
ES2545895T3 (es) Proteína de fusión anticancerígena
MX2020010806A (es) Peptidos anti-inflamatorios y usos de los mismos.
MX2022001134A (es) Proteinas quimericas de factor viii y usos de estas.
ES2691539T3 (es) Luciferasas de Oplophorus sintéticas con mayor emisión de luz
ES2676023T3 (es) Polipéptidos de IL-22 y proteínas de fusión de IL-22 Fc y métodos de uso
AR080229A1 (es) Proteinas de dominio de armazon de fibronectina que se unen a il -23 (interleucina 23)
MX343386B (es) Proteinas de fusion portadoras de peptido como vacunas para alergia.
ES2652643T3 (es) Péptidos terapéuticos y su uso contra la corea de Huntington
EA201791238A1 (ru) Способы и композиции, в которых используются варианты полипептидов klotho
AR076977A1 (es) Proteinas precursoras repetitivas autoensambladas
EA201491277A1 (ru) Противораковый слитый белок
CL2017000200A1 (es) Célula huésped mejorada para producir proteinas
JP2015524403A5 (es)
NZ706884A (en) Fc gamma receptor iib variants
MX2021013976A (es) Secuencias de direccionamiento para plataforma de visualizacion de endosporas basada en paenibacillus.
ES2663386T3 (es) Novirabdovirus recombinante utilizable como vector de antígenos
ES2572367T3 (es) Péptidos con epítopos de la MELK y vacunas que los contienen
HRP20190544T1 (hr) Ciklični analozi apelina